More about

Antiviral

News
September 26, 2024
2 min read
Save

'Encouraging': Antiviral ziresovir shows promise against RSV in infants

The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New England Journal of Medicine.

News
December 05, 2023
3 min read
Save

Study: Antiviral use remains low in children with flu

Use of antivirals to treat influenza in children remains low despite their wide availability and guidelines recommending their use, according to a study published in Pediatrics.

News
July 20, 2023
2 min read
Save

18% of nursing home residents with COVID-19 received antivirals during pandemic

Despite being at greater risk for adverse COVID-19 outcomes, just one in four nursing home residents with COVID-19 received antiviral treatment from May 31, 2021, through the end of 2022, researchers found.

News
July 20, 2023
3 min read
Save

Sublingual immunotherapy improves bronchial epithelial antiviral resistance

Sublingual immunotherapy for house dust mite allergic asthma improved bronchial epithelial antiviral resistance to viral infection, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

News
April 19, 2023
4 min read
Save

Q&A: How to treat outpatients with COVID-19

Mutations have allowed SARS-CoV-2 to evade previously effective treatments and preventives that have become a crucial tool for reducing severe COVID-19 and have made treating outpatients with COVID-19 more complicated.

News
March 23, 2023
4 min read
Save

Antiviral associated with 26% reduced risk for long COVID

The antiviral nirmatrelvir, which is part of Paxlovid, was linked to a significant reduction in the risk for long COVID and post-acute death in patients with at least one risk factor for severe illness, according to researchers.

News
November 08, 2022
2 min read
Save

Antiviral activity of VIR-2218 boosted by immunomodulators in treatment of chronic HBV

WASHINGTON — Pegylated interferon alpha potentiated the antiviral activity of VIR-2218 in a small subset of noncirrhotic patients with chronic hepatitis B, according to preliminary data presented at The Liver Meeting.

News
October 19, 2022
8 min read
Save

‘Inevitable’ or not? Experts debate antiviral resistance to COVID-19 drugs as data emerge

Although the emergency use authorizations for antiviral medications to treat COVID-19 have proven to be crucial in helping patients at high risk for severe disease, a potential wrinkle threatens to undo that progress.

News
October 11, 2022
2 min read
Save

HCV elimination unlikely to be hindered by suboptimal direct-acting antiviral efficacy

The efficacy of direct-acting antivirals in people with HIV and hepatitis C virus originating from Sub-Saharan Africa and southeastern Asia but living in Europe is high, according to a recent study published in Open Forum Infectious Diseases.

News
October 03, 2022
3 min read
Save

Clinical trial of antiviral for monkeypox goes forward as cases decline

Experts involved with an NIH trial of tecovirimat said that even as cases of monkeypox continue to decline nationally, it is important to establish whether the antiviral is effective against the infection.

View more